Skip to content

study to evaluate benefits of leech therapy in endometriosis

The effect of leech therapy in endometriosis an amphispective clinical study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106686
Enrollment
30
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N809- Endometriosis, unspecified

Interventions

Intervention1: Hirudinaria granulosa: patient will receive leech therapy (1 to 4) consecutively for the period of three menstrual cycles on suprapubic region with each session lasting for a period of

Sponsors

Government nizamia tibbi college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: females diagnosed with endometriosis with or without pelvic pain or secondary dysmenorrhea heavy menstrual bleeding patients willing to participate in the trail by signing informed consent

Exclusion criteria

Exclusion criteria: congenital malformation of the genital tract pelvic malignancy bleeding disorders severe anaemia hb less than 8 gm thrombocytopenia lactation first 6 months uncontrolled diabetes uncontrolled hypertension uncontrolled thyroid function

Design outcomes

Primary

MeasureTime frame
reduction in pain intensity assessed by visual analog scaleTimepoint: baseline 4 weeks 8 weeks 12 weeks

Secondary

MeasureTime frame
overall reduction in severity of dysmenorrhea and associated symtoms assessed by WaLIDD score SF 12 QOL questionnaire will be used to assess the intensity of pain and quality of life changes in usg for the size of endometriotic lesionTimepoint: baseline 12 weeks

Countries

India

Contacts

Public ContactDr A Suhasini

National Institute of Unani Medicine

drarshiya@yahoo.com9740915911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026